| An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota IB Jeffery, PW O'toole, L Öhman, MJ Claesson, J Deane, EMM Quigley, ... Gut 61 (7), 997-1006, 2012 | 1003 | 2012 |
| Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions L Öhman, M Simrén Nature reviews Gastroenterology & hepatology 7 (3), 163-173, 2010 | 769 | 2010 |
| Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome J Tap, M Derrien, H Törnblom, R Brazeilles, S Cools-Portier, J Doré, ... Gastroenterology 152 (1), 111-123. e8, 2017 | 629 | 2017 |
| Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD C Casén, HC Vebø, M Sekelja, FT Hegge, MK Karlsson, E Ciemniejewska, ... Alimentary pharmacology & therapeutics 42 (1), 71-83, 2015 | 350 | 2015 |
| Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies B Ahluwalia, L Moraes, MK Magnusson, L Öhman Scandinavian journal of gastroenterology 53 (4), 379-389, 2018 | 280 | 2018 |
| The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis A Lasson, PO Stotzer, L Öhman, S Isaksson, M Sapnara, H Strid Journal of Crohn's and Colitis 9 (1), 26-32, 2015 | 265 | 2015 |
| Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs SMP Bennet, L Böhn, S Störsrud, T Liljebo, L Collin, P Lindfors, ... Gut 67 (5), 872-881, 2018 | 253 | 2018 |
| Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad B Ahluwalia, MK Magnusson, L Öhman Scandinavian journal of gastroenterology 52 (11), 1185-1193, 2017 | 237 | 2017 |
| Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity N Holmén, A Lundgren, S Lundin, AM Bergin, A Rudin, H Sjövall, ... Inflammatory bowel diseases 12 (6), 447-456, 2006 | 227 | 2006 |
| New insights into the pathogenesis and pathophysiology of irritable bowel syndrome L Öhman, M Simren Digestive and liver disease 39 (3), 201-215, 2007 | 221 | 2007 |
| Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis M Bashashati, N Rezaei, A Shafieyoun, DP McKernan, L Chang, ... Neurogastroenterology & Motility 26 (7), 1036-1048, 2014 | 216 | 2014 |
| Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome–a randomized, double‐blind, controlled study M Simrén, L Öhman, J Olsson, U Svensson, K Ohlson, I Posserud, H Strid Alimentary pharmacology & therapeutics 31 (2), 218-227, 2010 | 212 | 2010 |
| T-cell activation in patients with irritable bowel syndrome L Öhman, S Isaksson, AC Lindmark, I Posserud, PO Stotzer, H Strid, ... Official journal of the American College of Gastroenterology| ACG 104 (5 …, 2009 | 212 | 2009 |
| Crosstalk at the mucosal border: importance of the gut microenvironment in IBS L Öhman, H Törnblom, M Simren Nature reviews Gastroenterology & hepatology 12 (1), 36-49, 2015 | 203 | 2015 |
| Gut microbiota as potential orchestrators of irritable bowel syndrome SMP Bennet, L Öhman, M Simrén Gut and liver 9 (3), 318, 2015 | 187 | 2015 |
| Intestinal microbiota and its role in irritable bowel syndrome (IBS) L Öhman, M Simrén Current gastroenterology reports 15, 1-7, 2013 | 167 | 2013 |
| Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition MK Magnusson, H Strid, M Sapnara, A Lasson, A Bajor, KA Ung, ... Journal of Crohn's and Colitis 10 (8), 943-952, 2016 | 162 | 2016 |
| Colonic immune cells in irritable bowel syndrome: a systematic review and meta‐analysis M Bashashati, S Moossavi, C Cremon, MR Barbaro, S Moraveji, G Talmon, ... Neurogastroenterology & Motility 30 (1), e13192, 2018 | 158 | 2018 |
| A controlled study of colonic immune activity and β7+ blood T lymphocytes in patients with irritable bowel syndrome L Öhman, S Isaksson, A Lundgren, M Simrén, H Sjövall Clinical Gastroenterology and Hepatology 3 (10), 980-986, 2005 | 145 | 2005 |
| Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis UA Wenzel, MK Magnusson, A Rydström, C Jonstrand, J Hengst, ... PloS one 9 (6), e100217, 2014 | 141 | 2014 |
